MDMichael Douglass

Michael Douglass

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Douglass has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multimodal PSOCT-NIRS catheter for guided ablation of atrial fibrillation

    by Michael Douglass, Reza Mohammadpour, Walter Hoyt, Ohad Ziv, Kenneth R. Laurita, Christine Hendon, Andrew M. Rollins

    SignificanceAtrial fibrillation is treated with thermal ablation to isolate ectopic signals. Although this is the current standard of care, recurrence occurs in up to 40% of cases. Clinicians have no reliable way to predict treatment durability intraoperatively. Adding the capability of direct optical measurement of the tissue to an ablation catheter could help better guide the treatment.AimA radiofrequency ablation catheter was developed with polarization-sensitive optical coherence tomography (PSOCT) and near-infrared spectroscopy (NIRS) to demonstrate, for the first time, simultaneous monitoring of thermal lesion formation.ApproachWe fabricated the multimodal PSOCT-NIRS ablation catheter and validated optical metrics using known targets of tissue-like phantom, deoxygenated blood, and atrial tissue. We then demonstrated recording PSOCT and NIRS data during ex vivo ablation of swine atria.ResultsPSOCT-NIRS metrics showed expected values in known targets. Measurements during ablation also exhibited previously reported patterns—OCT scattering increases, PSOCT birefringence decreases, and NIRS lesion optical index increases. Furthermore, simultaneous measurement revealed varying rates of change and magnitudes of response to different powers of thermal ablation.ConclusionsPSOCT-NIRS can measure tissue response to thermal energy delivery, and the optical metrics are complementary. By collecting more information during thermal energy delivery, PSOCT-NIRS metrics could contribute to understanding treatment durability in future investigations.

  • Open Access

    Image harmonization and deep learning automated classification of plus disease in retinopathy of prematurity

    by Ananya Subramaniam, Faruk Orge, Michael Douglass, Basak Can, Guillermo Monteoliva, Evelin Fried, Vanina Schbib, Gabriela Saidman, Brenda Peña, Soledad Ulacia, et al.

    Retinopathy of prematurity (ROP), a disease affecting preterm infants characterized by abnormal development of retinal blood vessels, is the leading preventable cause of infantile blindness.1,2 Plus disease is an indicator of ROP severity and is characterized by severe dilation and tortuosity of retinal blood vessels in the posterior pole.1,3,4 Once plus disease is identified, infants are treated using laser photocoagulation or anti-vascular endothelial growth factor (anti-VEGF) injections with great success.5,6 However, an incorrect diagnosis or lack of screening can prove detrimental as the onset of plus disease can result in blindness within two weeks if left untreated, with nearly 50,000 infants blinded due to ROP annually worldwide.7,8 Routine retinal examination by skilled ophthalmologists is critical for early detection and treatment of ROP.